Citadel Reduces Nvidia Stake While Boosting Intuitive Surgical by 30.3%
NVDA•Citadel Advisors trimmed its Nvidia stake in the first quarter while lifting its Intuitive Surgical holding by 30.3%. The shift comes as Citadel reallocates capital toward medical device AI opportunities despite headwinds like competition, lower margins and tariffs.
1. Citadel Reduces Nvidia Position in Q1
In the first quarter, Citadel Advisors scaled back its Nvidia holdings, signaling a rotation away from semiconductor exposure despite Nvidia’s strong AI-driven growth. The exact reduction was not disclosed, but the move underscores a reassessment of Nvidia’s valuation and risk profile amid lofty market expectations.
2. Citadel Increases Intuitive Surgical Stake by 30.3%
During the same period, Citadel raised its Intuitive Surgical position by 30.3%, citing the company’s competitive moat and AI integration potential in surgical robotics. This increased allocation comes despite pressures from competition, lower margins on new products and tariffs, reflecting confidence in the long-term addressable market for advanced medical devices.
